期刊文献+

阿维拉霉素生物合成与代谢调控研究进展 被引量:8

Advances on Biosynthesis Approach and Metabolic Regulation of Avilamycin
下载PDF
导出
摘要 阿维拉霉素是发酵法来源的新型兽用的消化促进剂和代谢调节剂,具有较高的生物安全性,通过改善动物肠道内细菌群的生态结构促进动物生长。对阿维拉霉素的生物合成和代谢调控进行了综述,同时结合系统生物技术观点,为阿维拉霉素菌种基因工程改造提供参考。 Avilamycin is a new type of digestive enhancer and metabolic modulater by fermentation technology,and has high biological safety level.Avilamycin can perfect the ecological structure of intestinal bacteria and promote the growth of animals.In this article,the biosynthesis progress and the metabolic regulative control of avilamycin were investigated,which provided some novel strategies to improve the production ability of strain by genetic engineering approach,combined with the view of system biotechnology.
出处 《生物技术通报》 CAS CSCD 北大核心 2010年第12期25-30,共6页 Biotechnology Bulletin
基金 重庆市自然科学基金项目(CSTC 2009BB1120) 重庆科技创新能力建设项目(CSTC 2009CB1010)
关键词 阿维拉霉素 生物安全发 生物合成 系统生物技术 Avilamycin Biological safety Biosynthesis System biotechnology
  • 相关文献

参考文献25

  • 1Magnussen JD, Dalidowicz JE, Thomson TD, et al. Tissue residues and metabolism of avilamycin in swine and rats. Journal of Agricultural and Food Chemistry, 1991,39 : 306-310.
  • 2Menotta S,Fedrizzi G, Macrl S, et al. Results of avilamycin residues monitoring plans for the experimental use in Italy. Veronal(Ztaly) : 9^th world Rabbit Congress,2008:1393-1398.
  • 3Katsunuma Y, Hanazumi M, Fujisaki H, et al, Influence of avitamycin administration and its subsequent withdrawal on emergence and disappearance of antimicrobial resistanee in enterococei in the intestine of broiler chickens. Journal of Applied Microbiology,2007,102: 1159-1166.
  • 4Delsol AA, Woodward M J, Roe JM. Effect of a 5-day enrofloxacin treatment on Salmonella enterica serotype Typhimurium DT104 in the pig. Journal of Antimicrobial Chemotherapy ,2004,53:396-398.
  • 5Delsol AA, Randall L,Cooles S, et al. Effect of the growth promoter avilamycin on emergence and persistence of antimicrobial resistance in enteric bacteria in the pig. Journal of Applied Microbiology,2005, 98:564-571.
  • 6Simjee S,Heffron AL,Agnoletti F,et al. Pharmaeodynamics of avilamycin towards strains of Clostridium perfringens isolated from epizootic rabbir enteropathy. Veronal (Ztaly) :9^th world Rabbit Congress, 2008 : 1085-1089.
  • 7Aarestrup FM, Seyfarth AM, Emborg HD, et al. Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark. Antimicrohial Agents and Chemotherapy, 2001,45 ( 7 ) : 2054-2059.
  • 8Castillo M, Martin-Orue SM, Roca M, et al. The response of gastrointestinal microbiota to avilamyein,butyrate, and plant extracts in early-weaned pigs. Journal of Animal Science,2006,84:2725-2734.
  • 9Weitnauer G, Hauser G, Hofmann C, et al. Novel avilamycin derivatives with improved polarity generated by targeted gene disruption. Chemistry & Biology,2004, 11:1403-1411.
  • 10陈永辉,刘波,曾兆国,李国泉.阿维拉霉素的研究进展[J].饲料工业,2007,28(14):9-11. 被引量:9

二级参考文献8

共引文献31

同被引文献76

引证文献8

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部